Nutra Pharma 10% holder lists 12M preferred shares

NUTRA PHARMA CORP (NPHC) had an initial ownership report filed by Pure Raw Supplies, LLC.

Rhea-AI Filing Summary

NUTRA PHARMA CORP (NPHC) had an initial ownership report filed by Pure Raw Supplies, LLC. The reporting entity is identified as a ten percent owner and discloses direct beneficial ownership of 12,000,000 Series B Preferred Shares. This Form 3 records holdings only, with no new transactions reported.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pure Raw Supplies, LLC

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Series B Preferred Shares	--	--	--

Holdings After Transaction: Series B Preferred Shares — 12,000,000 shares (Direct)

Key Figures

Series B Preferred Shares held: 12,000,000 shares

1 metrics

Series B Preferred Shares held 12,000,000 shares Total Series B Preferred Shares owned directly by Pure Raw Supplies, LLC following the reported position

Key Terms

Series B Preferred Shares, ten percent owner, beneficial ownership

3 terms

Series B Preferred Shares financial

"security_title: "Series B Preferred Shares""

Series B preferred shares are a class of company stock issued during a later round of private financing that gives investors priority over common shareholders for payouts and protections if the company is sold or liquidated. Think of them as a VIP ticket that often includes a fixed claim on returns, possible regular payments, and the option to convert into regular shares; that mix of safety and upside helps investors assess risk and potential reward.

ten percent owner regulatory

""is_ten_percent_owner": 1"

beneficial ownership regulatory

"This Form 3 records holdings only, with no new transactions reported."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position was reported in NPHC on this Form 3?

The Form 3 reports that Pure Raw Supplies, LLC is a ten percent owner of Nutra Pharma Corp and holds 12,000,000 Series B Preferred Shares directly. The filing records existing holdings rather than a new transaction.

How many shares does Pure Raw Supplies, LLC report owning in NPHC?

Pure Raw Supplies, LLC reports direct beneficial ownership of 12,000,000 Series B Preferred Shares of Nutra Pharma Corp following the reported position.

What type of security does the insider hold in NPHC?

The insider, Pure Raw Supplies, LLC, holds Series B Preferred Shares of Nutra Pharma Corp, with a reported balance of 12,000,000 shares owned directly.

Does this NPHC Form 3 show any insider buy or sell transactions?

No. The Form 3 functions as an initial statement of beneficial ownership and shows a holding entry of 12,000,000 Series B Preferred Shares with no associated purchase or sale transaction reported.

Is the ownership reported by Pure Raw Supplies, LLC in NPHC direct or indirect?

The filing classifies the 12,000,000 Series B Preferred Shares held by Pure Raw Supplies, LLC as direct beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 03:48 PM EDT Accepted by SEC EDGAR 09/01/2026 - 03:47 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pure Raw Supplies, LLC

(Last) (First) (Middle)

7915 NW 111TH WAY

(Street)

PARKLAND FLORIDA 33076

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/21/2026

3. Issuer Name and Ticker or Trading Symbol
NUTRA PHARMA CORP [ NPHC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Series B Preferred Shares	12,000,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Elizabeth Deitsch	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)